Biophagy signs an option with STC.UNM to license and develop autophagy-related technologies and molecules created at the University of New Mexico By jordan|2022-02-01T19:05:40+00:00February 1, 2022|2013-announcements|0 Comments Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTelegramTumblrPinterestVkXingEmail About the Author: jordan Related Posts Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico. Dr. Mary Ortner, Biophagy’s CEO, is elected vice president of the NM Biotechnology and Biomedical Association (NMBio), the BIO-affiliated NM trade association for bioscience in New Mexico. Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology. Dr. Steven Bradfute accepts a consulting position with Biophagy. He will advise the company and conduct assays in immunology and virology. Mary Ortner, PhD, MBA, accepts the position of president and CEO. She was previously SVP, business development and corporate alliances, at BioXcel Corporation. Mary Ortner, PhD, MBA, accepts the position of president and CEO. She was previously SVP, business development and corporate alliances, at BioXcel Corporation. Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.
Leave A Comment